Main clinical and biologic features of the patients with childhood AML analyzed
. | Total . | . | NPN1 wt . | . | NPM1 mut . | . | NPM1 mutated within subgroup, % . | |||
---|---|---|---|---|---|---|---|---|---|---|
. | n . | % total . | n . | % total . | n . | % total . | . | |||
Total | 107 | 100 | 100 | 93.5 | 7 | 6.5 | 0 | |||
Sex | ||||||||||
Male | 55 | 51.4 | 51 | 51.0 | 4 | 57.1 | 7.3 | |||
Female | 52 | 48.6 | 49 | 49.0 | 3 | 42.9 | 5.8 | |||
Age | ||||||||||
Median | ||||||||||
Younger than 5 y | 37 | 34.6 | 36 | 36.0 | 1 | 14.3 | 2.7 | |||
5-10 y | 25 | 23.4 | 24 | 24.0 | 1 | 14.3 | 4.0 | |||
Older than 10 y | 45 | 42.1 | 40 | 40.0 | 5 | 71.4 | 11.1 | |||
FAB* | ||||||||||
M0 | 6 | 6.3 | 6 | 6.7 | 0 | 0 | 0 | |||
M1 | 21 | 21.9 | 20 | 22.5 | 1 | 14.3 | 4.8 | |||
M2 | 19 | 19.8 | 17 | 19.1 | 2 | 28.6 | 10.5 | |||
M4 | 13 | 13.5 | 10 | 11.2 | 3 | 42.9 | 23.1 | |||
M4eo | 8 | 8.3 | 8 | 9.0 | 0 | 0 | 0 | |||
M5 | 18 | 18.8 | 18 | 20.2 | 0 | 0 | 0 | |||
M6 | 3 | 3.1 | 2 | 2.2 | 1 | 14.3 | 33.3 | |||
M7 | 8 | 8.3 | 8 | 9.0 | 0 | 0 | 0 | |||
Karyotype* | ||||||||||
Normal | 26 | 27.1 | 19 | 21.3 | 7 | 100.0 | 26.9 | |||
t(8;21) | 17 | 17.7 | 17 | 19.1 | 0 | 0 | 0 | |||
inv(16)/t(16;16) | 8 | 8.3 | 8 | 9.0 | 0 | 0 | 0 | |||
t(11q23) | 18 | 18.8 | 18 | 20.2 | 0 | 0 | 0 | |||
Trysomy 8 | 4 | 4.2 | 4 | 4.5 | 0 | 0 | 0 | |||
− | 6 | 6.3 | 6 | 6.7 | 0 | 0 | 0 | |||
Other/Complex | 17 | 17.7 | 17 | 19.1 | 0 | 0 | 0 | |||
1680- | 5450- | |||||||||
WBC, × 106/L | 35 500 | 1680-475 000† | 35 650 | 475 000† | 16 000 | 113 900† | NA |
. | Total . | . | NPN1 wt . | . | NPM1 mut . | . | NPM1 mutated within subgroup, % . | |||
---|---|---|---|---|---|---|---|---|---|---|
. | n . | % total . | n . | % total . | n . | % total . | . | |||
Total | 107 | 100 | 100 | 93.5 | 7 | 6.5 | 0 | |||
Sex | ||||||||||
Male | 55 | 51.4 | 51 | 51.0 | 4 | 57.1 | 7.3 | |||
Female | 52 | 48.6 | 49 | 49.0 | 3 | 42.9 | 5.8 | |||
Age | ||||||||||
Median | ||||||||||
Younger than 5 y | 37 | 34.6 | 36 | 36.0 | 1 | 14.3 | 2.7 | |||
5-10 y | 25 | 23.4 | 24 | 24.0 | 1 | 14.3 | 4.0 | |||
Older than 10 y | 45 | 42.1 | 40 | 40.0 | 5 | 71.4 | 11.1 | |||
FAB* | ||||||||||
M0 | 6 | 6.3 | 6 | 6.7 | 0 | 0 | 0 | |||
M1 | 21 | 21.9 | 20 | 22.5 | 1 | 14.3 | 4.8 | |||
M2 | 19 | 19.8 | 17 | 19.1 | 2 | 28.6 | 10.5 | |||
M4 | 13 | 13.5 | 10 | 11.2 | 3 | 42.9 | 23.1 | |||
M4eo | 8 | 8.3 | 8 | 9.0 | 0 | 0 | 0 | |||
M5 | 18 | 18.8 | 18 | 20.2 | 0 | 0 | 0 | |||
M6 | 3 | 3.1 | 2 | 2.2 | 1 | 14.3 | 33.3 | |||
M7 | 8 | 8.3 | 8 | 9.0 | 0 | 0 | 0 | |||
Karyotype* | ||||||||||
Normal | 26 | 27.1 | 19 | 21.3 | 7 | 100.0 | 26.9 | |||
t(8;21) | 17 | 17.7 | 17 | 19.1 | 0 | 0 | 0 | |||
inv(16)/t(16;16) | 8 | 8.3 | 8 | 9.0 | 0 | 0 | 0 | |||
t(11q23) | 18 | 18.8 | 18 | 20.2 | 0 | 0 | 0 | |||
Trysomy 8 | 4 | 4.2 | 4 | 4.5 | 0 | 0 | 0 | |||
− | 6 | 6.3 | 6 | 6.7 | 0 | 0 | 0 | |||
Other/Complex | 17 | 17.7 | 17 | 19.1 | 0 | 0 | 0 | |||
1680- | 5450- | |||||||||
WBC, × 106/L | 35 500 | 1680-475 000† | 35 650 | 475 000† | 16 000 | 113 900† | NA |